Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Acute Gastroenteritis | Research article

Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain

Authors: Raúl Pérez-Ortín, Cristina Santiso-Bellón, Susana Vila-Vicent, Noelia Carmona-Vicente, Jesús Rodríguez-Díaz, Javier Buesa

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Human group A rotavirus is the leading cause of severe acute gastroenteritis in young children worldwide. Immunization programs have reduced the disease burden in many countries. Vaccination coverage in the Autonomous Region of Valencia, Spain, is around 40%, as the rotavirus vaccine is not funded by the National Health System. Despite this low-medium vaccine coverage, rotavirus vaccination has substantially reduced hospitalizations due to rotavirus infection and hospital-related costs. However, there are very few studies evaluating symptomatic rotavirus infections not requiring hospitalization in vaccinated children. The objective of this study was to investigate symptomatic rotavirus infections among vaccinated children in the health area served by the Hospital Clínico Universitario of Valencia, Spain, from 2013 to 2015.

Methods

A total of 133 children younger than 5 years of age with rotavirus infection were studied. Demographic and epidemiological data were collected and informed consent from their caretakers obtained. Rotavirus infection was detected by immunological methods and G/P rotavirus genotypes were determined by RT-PCR, following standard procedures from the EuroRotaNet network.

Results

Forty infants (30.1%; 95% CI: 22.3–37.9) out of 133 were diagnosed with symptomatic rotavirus infection despite having been previously vaccinated, either with RotaTeq (85%) or with Rotarix (15%). Children fully vaccinated against rotavirus (24.8%), partially vaccinated (5.3%) and unvaccinated (69.9%) were found. The infecting genotypes showed high G-type diversity, although no significant differences were found between the G/P genotypes infecting vaccinated and unvaccinated children during the same time period. G9P[8], G12P[8] and G1P[8] were the most prevalent genotypes. Severity of gastroenteritis symptoms required 28 (66.6%) vaccinated and 67 (73.6%) unvaccinated children to be attended at the Emergency Room.

Conclusion

Rotavirus vaccine efficacy in reducing the incidence of severe rotavirus infection has been well documented, but symptomatic rotavirus infection can sometimes occur in vaccinees.
Literature
1.
go back to reference WHO. Rotavirus vaccines WHO position paper: January 2013 – Recommendations. Vaccine. 2013;31(52):6170–1.CrossRef WHO. Rotavirus vaccines WHO position paper: January 2013 – Recommendations. Vaccine. 2013;31(52):6170–1.CrossRef
2.
go back to reference Velázquez FR. Protective effects of natural rotavirus infection. Pediatr Infect Dis J. 2009;28(Supplement):S54–6.PubMedCrossRef Velázquez FR. Protective effects of natural rotavirus infection. Pediatr Infect Dis J. 2009;28(Supplement):S54–6.PubMedCrossRef
4.
go back to reference Hoffmann T, Iturriza-Gómara M, Faaborg-Andersen J, Kraaer C, Nielsen CP, Gray J, et al. Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families. Eur J Pediatr. 2011;170(12):1535–9.PubMedCrossRef Hoffmann T, Iturriza-Gómara M, Faaborg-Andersen J, Kraaer C, Nielsen CP, Gray J, et al. Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families. Eur J Pediatr. 2011;170(12):1535–9.PubMedCrossRef
5.
go back to reference Marinosci A, Doit C, Koehl B, Belhacel K, Mariani Kurkdjian P, Melki I, et al. Gastro-entérites nosocomiales à rotavirus: étude rétrospective dans un service de pédiatrie générale. Arch Pédiatrie. 2016;23(11):1118–23.CrossRef Marinosci A, Doit C, Koehl B, Belhacel K, Mariani Kurkdjian P, Melki I, et al. Gastro-entérites nosocomiales à rotavirus: étude rétrospective dans un service de pédiatrie générale. Arch Pédiatrie. 2016;23(11):1118–23.CrossRef
6.
go back to reference Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41.PubMedCrossRef Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41.PubMedCrossRef
7.
go back to reference Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–65.PubMedPubMedCentralCrossRef Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–65.PubMedPubMedCentralCrossRef
8.
go back to reference Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565–72.PubMedPubMedCentralCrossRef Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565–72.PubMedPubMedCentralCrossRef
9.
go back to reference Alvarez-Aldeán J, Aristegui J, López-Belmonte JL, Pedrós M, García-Sicilia J. Economic and psychosocial impact of rotavirus infection in Spain: a literature review. Vaccine. 2014;32(30):3740–51.PubMedCrossRef Alvarez-Aldeán J, Aristegui J, López-Belmonte JL, Pedrós M, García-Sicilia J. Economic and psychosocial impact of rotavirus infection in Spain: a literature review. Vaccine. 2014;32(30):3740–51.PubMedCrossRef
10.
go back to reference Díez-Domingo J, Suriñach NL, Alcalde NM, Betegón L, Largeron N, Trichard M. Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010;10(1):469.PubMedPubMedCentralCrossRef Díez-Domingo J, Suriñach NL, Alcalde NM, Betegón L, Largeron N, Trichard M. Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010;10(1):469.PubMedPubMedCentralCrossRef
11.
12.
go back to reference Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.PubMedCrossRef Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.PubMedCrossRef
13.
go back to reference Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine. N Engl J Med. 2006;354(1):23–33.PubMedCrossRef Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine. N Engl J Med. 2006;354(1):23–33.PubMedCrossRef
14.
go back to reference Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–14.PubMedCrossRef Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–14.PubMedCrossRef
15.
go back to reference Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–98.PubMedCrossRef Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–98.PubMedCrossRef
16.
go back to reference WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009: Conclusions and recommendations. Biologicals. 2010;38(1):170–7.CrossRef WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009: Conclusions and recommendations. Biologicals. 2010;38(1):170–7.CrossRef
17.
go back to reference Chavers T, De Oliveira LH, Parashar UD, Tate JE. Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis. Expert Rev. Vaccines. 2018;17(11):1037–51.PubMedCrossRef Chavers T, De Oliveira LH, Parashar UD, Tate JE. Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis. Expert Rev. Vaccines. 2018;17(11):1037–51.PubMedCrossRef
18.
go back to reference Araki K, Hara M, Tsugawa T, Shimanoe C, Nishida Y, Matsuo M, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children. Vaccine. 2018;36(34):5187–93.PubMedCrossRef Araki K, Hara M, Tsugawa T, Shimanoe C, Nishida Y, Matsuo M, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children. Vaccine. 2018;36(34):5187–93.PubMedCrossRef
19.
go back to reference Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact. Expert Rev. Vaccines. 2018;17(7):593–606.PubMedCrossRef Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact. Expert Rev. Vaccines. 2018;17(7):593–606.PubMedCrossRef
20.
go back to reference Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015;33(18):2097–107.PubMedCrossRef Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015;33(18):2097–107.PubMedCrossRef
21.
go back to reference Mwenda JM, Parashar UD, Cohen AL, Tate JE. Impact of rotavirus vaccines in Sub-Saharan African countries. Vaccine. 2018;36(47):7119–23.PubMedCrossRef Mwenda JM, Parashar UD, Cohen AL, Tate JE. Impact of rotavirus vaccines in Sub-Saharan African countries. Vaccine. 2018;36(47):7119–23.PubMedCrossRef
22.
go back to reference Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan MF, Díez Domingo J, Garcés Sánchez M, et al. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2008. An Pediatría. 2008;68(1):63–9.CrossRef Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan MF, Díez Domingo J, Garcés Sánchez M, et al. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2008. An Pediatría. 2008;68(1):63–9.CrossRef
23.
go back to reference Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region. Spain. BMC Infect Dis. 2015;15(1):92.PubMedCrossRef Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region. Spain. BMC Infect Dis. 2015;15(1):92.PubMedCrossRef
24.
go back to reference Orrico-Sanchez A, López-Lacort M, Pérez-Vilar S, Díez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region. Spain. BMC Infect Dis. 2017;17(1):267.PubMedCrossRef Orrico-Sanchez A, López-Lacort M, Pérez-Vilar S, Díez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region. Spain. BMC Infect Dis. 2017;17(1):267.PubMedCrossRef
25.
go back to reference Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666–72.PubMedCrossRef Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666–72.PubMedCrossRef
27.
go back to reference Glass RI, Jiang B, Parashar U. The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem? Vaccine. 2018;36(17):2233–6.PubMedCrossRef Glass RI, Jiang B, Parashar U. The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem? Vaccine. 2018;36(17):2233–6.PubMedCrossRef
28.
go back to reference Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, et al. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012;206(8):1275–9.PubMedCrossRef Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, et al. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012;206(8):1275–9.PubMedCrossRef
29.
go back to reference Santos CB, Araújo KCGM, Jardim-Botelho A, Bezerra Santos M, Rodrigues A, Santana Dolabella S, et al. Diarrhea incidence and intestinal infections among rotavirus vaccinated infants from a poor area in Brazil: a spatial analysis. BMC Public Health. 2014;14(1):399.PubMedPubMedCentralCrossRef Santos CB, Araújo KCGM, Jardim-Botelho A, Bezerra Santos M, Rodrigues A, Santana Dolabella S, et al. Diarrhea incidence and intestinal infections among rotavirus vaccinated infants from a poor area in Brazil: a spatial analysis. BMC Public Health. 2014;14(1):399.PubMedPubMedCentralCrossRef
30.
go back to reference Gautam R, Lyde F, Esona MD, Quaye O, Bowen MD. Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens. J Clin Virol. 2013;58(1):292–4.PubMedPubMedCentralCrossRef Gautam R, Lyde F, Esona MD, Quaye O, Bowen MD. Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens. J Clin Virol. 2013;58(1):292–4.PubMedPubMedCentralCrossRef
31.
go back to reference Buesa J, Montava R, Abu-Mallouh R, Fos M, Ribes JM, Bartolomé R, et al. Sequential evolution of genotype GII.4 norovirus variants causing gastroenteritis outbreaks from 2001 to 2006 in Eastern Spain. J Med Virol. 2008;80(7):1288–95.PubMedCrossRef Buesa J, Montava R, Abu-Mallouh R, Fos M, Ribes JM, Bartolomé R, et al. Sequential evolution of genotype GII.4 norovirus variants causing gastroenteritis outbreaks from 2001 to 2006 in Eastern Spain. J Med Virol. 2008;80(7):1288–95.PubMedCrossRef
32.
go back to reference Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28(3):495–503.PubMedPubMedCentral Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28(3):495–503.PubMedPubMedCentral
33.
go back to reference Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532–4 536–7.PubMed Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532–4 536–7.PubMed
34.
go back to reference Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, et al. Rotavirus surveillance in Europe, 2005–2008: Web-Enabled reporting and Real-Time analysis of genotyping and epidemiological data. J Infect Dis. 2009;200(s1):S215–21.PubMedCrossRef Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, et al. Rotavirus surveillance in Europe, 2005–2008: Web-Enabled reporting and Real-Time analysis of genotyping and epidemiological data. J Infect Dis. 2009;200(s1):S215–21.PubMedCrossRef
35.
go back to reference Weaver KF, Morales V, Dunn SL, Godde K, Weaver PF. An introduction to statistical analysis in research: with applications in the biological and life sciences. Hoboken: Wiley.; 2017. p. 393–434.CrossRef Weaver KF, Morales V, Dunn SL, Godde K, Weaver PF. An introduction to statistical analysis in research: with applications in the biological and life sciences. Hoboken: Wiley.; 2017. p. 393–434.CrossRef
36.
37.
go back to reference Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12(1):213.PubMedPubMedCentralCrossRef Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12(1):213.PubMedPubMedCentralCrossRef
38.
go back to reference Lopez-Lacort M, Collado S, Díez-Gandía A, Díez-Domingo J. Rotavirus, vaccine failure or diagnostic error? Vaccine. 2016;34(48):5912–5.PubMedCrossRef Lopez-Lacort M, Collado S, Díez-Gandía A, Díez-Domingo J. Rotavirus, vaccine failure or diagnostic error? Vaccine. 2016;34(48):5912–5.PubMedCrossRef
39.
go back to reference Bucardo F, Reyes Y, Rönnelid Y, González F, Sharma S, Svensson L, et al. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants. Sci Rep. 2019;9(1):10764.PubMedPubMedCentralCrossRef Bucardo F, Reyes Y, Rönnelid Y, González F, Sharma S, Svensson L, et al. Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants. Sci Rep. 2019;9(1):10764.PubMedPubMedCentralCrossRef
40.
go back to reference Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8(10):642–9.PubMedCrossRef Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8(10):642–9.PubMedCrossRef
41.
go back to reference Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis D, et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine. 1998;16(4):381–7.PubMedCrossRef Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis D, et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine. 1998;16(4):381–7.PubMedCrossRef
42.
go back to reference Bányai K, László B, Duque J, Steele AD, Nelson EAS, Gentsch JR, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30:A122–30.PubMedCrossRef Bányai K, László B, Duque J, Steele AD, Nelson EAS, Gentsch JR, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30:A122–30.PubMedCrossRef
43.
go back to reference Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U, et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: Is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446–61.PubMedCrossRefPubMedCentral Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U, et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: Is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446–61.PubMedCrossRefPubMedCentral
44.
go back to reference Zeller M, Patton JT, Heylen E, De Coster S, Ciarlet M, Van Ranst M, et al. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol. 2012;50(3):966–76.PubMedPubMedCentralCrossRef Zeller M, Patton JT, Heylen E, De Coster S, Ciarlet M, Van Ranst M, et al. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol. 2012;50(3):966–76.PubMedPubMedCentralCrossRef
45.
go back to reference Ogden KM, Tan Y, Akopov A, Stewart LS, McHenry R, Fonnesbeck CJ, et al. Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States. J Virol. 2018;93(1):e01476–18. Ogden KM, Tan Y, Akopov A, Stewart LS, McHenry R, Fonnesbeck CJ, et al. Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States. J Virol. 2018;93(1):e01476–18.
46.
go back to reference Bucardo F, Mercado J, Reyes Y, González F, Balmaseda A, Nordgren J. Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua. Clin Microbiol Infect. 2015;21(6):603.e1–7.CrossRef Bucardo F, Mercado J, Reyes Y, González F, Balmaseda A, Nordgren J. Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua. Clin Microbiol Infect. 2015;21(6):603.e1–7.CrossRef
47.
go back to reference Vesikari T, Prymula R, Schuster V, Tejedor J-C, Cohen R, Bouckenooghe A, et al. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J. 2012;31(5):509–13.PubMedCrossRef Vesikari T, Prymula R, Schuster V, Tejedor J-C, Cohen R, Bouckenooghe A, et al. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J. 2012;31(5):509–13.PubMedCrossRef
48.
go back to reference Monedero V, Buesa J, Rodríguez-Díaz J. The interactions between host glycobiology, bacterial microbiota, and viruses in the gut. Viruses. 2018;10(2):96.PubMedCentralCrossRef Monedero V, Buesa J, Rodríguez-Díaz J. The interactions between host glycobiology, bacterial microbiota, and viruses in the gut. Viruses. 2018;10(2):96.PubMedCentralCrossRef
49.
go back to reference Böhm R, Fleming FE, Maggioni A, Dang VT, Holloway G, Coulson BS, et al. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion. Nat Commun. 2015;6(1):5907.PubMedCrossRef Böhm R, Fleming FE, Maggioni A, Dang VT, Holloway G, Coulson BS, et al. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion. Nat Commun. 2015;6(1):5907.PubMedCrossRef
50.
go back to reference Pérez-Ortín R, Vila-Vicent S, Carmona-Vicente N, Santiso-Bellón C, Rodríguez-Díaz J, Buesa J. Histo-blood group antigens in children with symptomatic rotavirus infection. Viruses. 2019;11(4):339.PubMedCentralCrossRef Pérez-Ortín R, Vila-Vicent S, Carmona-Vicente N, Santiso-Bellón C, Rodríguez-Díaz J, Buesa J. Histo-blood group antigens in children with symptomatic rotavirus infection. Viruses. 2019;11(4):339.PubMedCentralCrossRef
51.
go back to reference Bucardo F, Rippinger CM, Svensson L, Patton JT. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol. 2012;12(6):1282–94.PubMedPubMedCentralCrossRef Bucardo F, Rippinger CM, Svensson L, Patton JT. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol. 2012;12(6):1282–94.PubMedPubMedCentralCrossRef
52.
go back to reference Pitzer VE, Patel MM, Lopman BA, Viboud C, Parashar UD, Grenfell BT. Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proc Natl Acad Sci. 2011;108(48):19353–8.PubMedCrossRefPubMedCentral Pitzer VE, Patel MM, Lopman BA, Viboud C, Parashar UD, Grenfell BT. Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proc Natl Acad Sci. 2011;108(48):19353–8.PubMedCrossRefPubMedCentral
Metadata
Title
Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain
Authors
Raúl Pérez-Ortín
Cristina Santiso-Bellón
Susana Vila-Vicent
Noelia Carmona-Vicente
Jesús Rodríguez-Díaz
Javier Buesa
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4550-x

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.